Ключевые слова:
surunkali yurak yetishmovchiligi, kardiorenal sindrom, erta bosqichlar, patogenez, biomarkerlar, neyrogumoral tizimlar.Библиографические ссылки
Ronco C, Bellasi A, Di Lullo L. Cardiorenal syndrome: An overview. Heart Failure Reviews. 2021;26(2):337–349.
Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies. Journal of the American College of Cardiology. 2021;77(17):2160–2180.
Damman K, Valente MAE, Voors AA, et al. Renal impairment, worsening renal function, and outcome in patients with heart failure. European Heart Journal. 2021;42(6):489–499.
House AA, Anand I, Bellomo R, et al. Definition and classification of cardiorenal syndromes. Journal of Cardiac Failure. 2021; 27(3):372–381.
Virzì GM, Clementi A, de Cal M, et al. Pathophysiology of cardiorenal syndrome. Contributions to Nephrology. 2021;198:9–20.
Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion. European Heart Journal. 2022;43 (5):418–432.
Testani JM, Brisco MA, Tang WHW, et al. Renal dysfunction in acute and chronic heart failure. Journal of the American College of Cardiology. 2022;79(11):1141–1156.
Sato A, Aonuma K. Neurohormonal activation in heart failure and cardiorenal syndrome. Heart Failure Clinics. 2022;18(2): 221–232.
Gupta R, Birnbaum Y, Uretsky BF. The renal consequences of heart failure. American Journal of Medicine. 2022;135(3):289–297.
McCullough PA, Kellum JA, Haase M, et al. Pathophysiology of the cardiorenal syndromes. Critical Care Clinics. 2022;38(3):381–394.
Di Lullo L, Reeves PB, Bellasi A, Ronco C. Cardiorenal syndrome in heart failure. Seminars in Nephrology. 2022;42(4):348–361.
Palazzuoli A, Ruocco G, Pellegrini M, et al. Cystatin C and renal dysfunction in heart failure. International Journal of Cardiology. 2022;360:105–111.
Hata N, Yokoyama S, Shinada T, et al. Prognostic value of cystatin C in patients with chronic heart failure. ESC Heart Failure. 2023; 10(1):398–407.
Ibrahim NE, Januzzi JL. Natriuretic peptides in heart failure diagnosis and management. Cardiology Clinics. 2023;41(1):33–46.
Maisel AS, Clopton P, Krishnaswamy P, et al. NT-proBNP in heart failure and cardiorenal interactions. Journal of the American College of Cardiology. 2023;81(14):1323–1334.
Damman K, Gori M, Claggett B, et al. Renal effects and associated outcomes during angiotensin–neprilysin inhibition. European Heart Journal. 2023;44(9):783–794.
Böhm M, Young R, Jhund PS, et al. SGLT2 inhibitors and cardiorenal outcomes in heart failure. The Lancet. 2023;401(10378): 733–744.
Packer M. Kallikrein–kinin system in cardiovascular and renal disease. Circulation Research. 2023;132(5):597–612.
Basuli D, Tesfaye S, Cooper ME. Kinin receptors in renal and cardiovascular pathology. Kidney International. 2023;104(4): 685–697.
Vaduganathan M, Claggett BL, Jhund PS, et al. Effects of sacubitril/valsartan on renal outcomes. Journal of the American College of Cardiology. 2024;83(2):155–167.
Greene SJ, Butler J, Fonarow GC. Early identification of cardiorenal syndrome. Journal of the American Heart Association. 2024;13(4):e029845.
McDonagh TA, Metra M, Adamo M, et al. 2023 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2023;44(4):359–472.
Verbrugge FH, Dupont M, Steels P, et al. Renal function and prognosis in chronic heart failure. Heart. 2024;110(3):185–193.
Ronco C, McCullough P, Anker SD, et al. Cardiorenal syndromes: Updated consensus. Nature Reviews Nephrology. 2024;20(2): 77–93.
Seferović PM, Coats AJS, Ponikowski P, et al. Biomarkers in heart failure and cardiorenal syndrome. European Journal of Heart Failure. 2024;26(5):945–959.
Voors AA, Gori M, Liu LCY, et al. Renal effects of heart failure therapies. Heart Failure Reviews. 2024;29(1):89–102.
Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment and renal outcomes. The Lancet. 2024; 403(10425):142–154.
Damman K, Beusekamp JC, Boorsma EM, et al. Worsening renal function in heart failure revisited. European Journal of Heart Failure. 2025;27(1):12–25.
Januzzi JL, Ahmad T. Biomarkers and early cardiorenal syndrome. JACC: Heart Failure. 2025;13(2):145–158.
Ronco C, Bellomo R. Cardiorenal syndrome: Toward integrated management. Kidney International. 2025;107(1):1–14.